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Abstract:. The study investigated the Effect of Corporate Governance Structure and Financial 
reporting quality of quoted Pharmaceutical companies in Nigeria. A total of ten Pharmaceutical 
companies were used from 2006-2019. Data were extracted from the annual report and accounts of 
the Pharmaceutical companies in Nigeria. Financial reporting quality was calculated using Dechow 
and Dicher’s (2002) model. The Housman test of multiple regression analysis was employed to test 
the hypotheses. The result found that Board independence has a positive effect on the financial 
reporting quality, Board compositions have a positive and significant effect on financial reporting 
quality, Board meeting has negative association on the financial reporting quality of 
pharmaceutical companies in Nigeria. The ownership structure also reflects the positive and 
significant financial reporting quality of the selected companies. The number of times the risk 
management committee meets yearly as an indicator of corporate governance structure yield a 
positive influence on the financial reporting quality of selected pharmaceutical companies. The 
result for a ratio of female members in the board, i.e. gender composition and numerical strength of 
Audit committee members each, is yielding positive and significant effect on financial reporting 
quality. The r-squared outcome of 55% implies the ability of the selected pharmaceutical companies 
in Nigeria. The regression model is also supported by the outcome of Durbin-Watson statistics which 
is close to 2, indicating the possible absence of autocorrelated in the regression model. It, therefore, 
recommends that quoted firms should adhere to the guidelines given by CBN and SEC on the code of 
corporate governance as it affects their financial reporting quality. Regular and spontaneous 
supervising functions/checks by the different regulating agencies are also recommended. 
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Financial Reporting is concepts that emerge first from formal record-keeping by 
organized business and Government. The issue of financial reporting is to provide 
investors, shareholders, and creditors with information that is useful for decision making, 
thus, to present users with transparent financial statements enhance decision making and 
avert business failure, which we have to maintain high-quality financial report. 
 
The recent successive financial crises and the resulting confidence crisis in financial 
reporting within information and economic framework has drawn the world’s attention 
to the role of corporate governance in ensuring the quality of the financial reporting 
processes, reducing fraud and false statements. This is especially after the scandals of big 
companies such as Enron in the United Kingdom and the collapse of WorldCom in the 
United States in 2001 and 2002, respectively. 
 
One of the implementations of financial statements in the company is to improve business 
decisions. Investors and creditors use the financial statement as a tool to make investment 
decisions and loans. The financial statement shows how the company obtains its resources 
(funding), where and how the resources are used (investment), and how effective the use 
of those resources (profitability of operational) (Lice & Istian, 2008). 
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Following the wave of accounting scandals that occurred recently both in international 
communities and local, this has raised so much criticism about the financial reporting 
quality (Agrawal & Chadha, 2008;). The widespread failure in the financial disclosure has 
created the need to improve the financial information quality and to strengthen the 
control of managers by setting up a good governance structure (Karamaou & Vateas, 
2005). This is because the presentation of credible, acceptable, and reliable financial 
reports is the fundamental basis of decision-making in any organization (Ojeka, Iyoha, & 
Obigbemi, 2014). With this, users of financial statements become worried when high-
profile businesses collapsed, and financial frauds were reported in renowned firms-
including large companies like Enron, WorldCom, Tyco, and Global Crossing (Hwang & 
Staley, 2005). Following these corporate failures, the governments of different countries 
came together to form Corporate Governance, which will now look into the affairs of the 
different businesses so that any financial statement that is coming out will be free and fire 
without basis. Responding to this, the US congress crested the Sarbanes-Oxley Act in 2002 
and introduced a new era of corporate governance, incorporating requirements for 
auditors’ independence, independence of firms audit committee, the responsibility of a 
firm’s Chief Executive (CEO), and Chief Financial officer (CFO) for the financial report and 
the protection of whistleblowers. This single act made corporate governance in 
developing and developing countries a crucial mechanism for government regulation of 
private and public companies. Our country Nigeria is not exempted from fraudulent 
financial cases, and corporate governance failures were equally reported, such as Cadbury 
Plc, Nigeria Telecommunication Limited (NITEL), Nigeria Coal Corporation (NCC), and 
Leventis Plc. The Banking sector is not left along with the unprecedented cases of non-
performing loans in the Nigerian banking industry that consumed banks such as 
International Bank Plc. Oceanic Bank, Bank PHB, and Afribank Plc all led to a significant 
review of corporate governance regulatory reforms in Nigeria and some other developing 
economics (Adeyemi, Dabor, & Okpala, 2012). 
 
Corporate governance refers to the process that seeks to direct and control the affairs of 
an organization, to protect the interest of all stakeholders in a balanced manner with the 
application of the principles of openness, integrity, and accountability (Obeten, Ocheri, & 
John, 2014). Gabrielsen, Gramlicn, and Phenbong (2012) defined corporate governance as 
all encompassing-it concerns how corporate entities are managed and regulated, and 
involves accountability, trust, honesty, and stewardship on the one hand and supervision, 
control monitoring oversight, and ensuring quality financial reporting on the other hand. 
 
The Pharmaceutical sector in any economy plays a prominent role in the general health of 
citizens residing in the country. Nigeria is not an exception, owing to its significance in the 
general welfare of the economy; it is the imperative general welfare of the economy, this 
imperative to give serious attention to issues that concern this sector. The Nigeria 
Pharmaceutical sector is known to be complex as it involves numerous players 
(Manufactures, national regulators, wholesalers and retailers, government ministries, and 
other stakeholders). This means that there is a need for these stakeholders to put in 
additional effort to create an enabling environment to exploit the full potentials of the 
sector. The pharmaceutical Manufacturers Group of Manufacturers Association of Nigeria 
(PMG-MAN, 2010) asserted that the Nigerian pharmaceutical sector has the potential to 
be a leader in the production and distribution of pharmaceuticals in Nigeria. 
 
Although Nigeria has a large human Capital (approximately 190 million people) and vast 
natural resources, the country is still fraught with poverty, diseases, and malnutrition 
(World Health Organization, 2103). The World Health Organization (WHO) rated Nigeria’s 
health sector 187th out of 191 members (WHO 2000). The Nigeria business environment 
is being seen in some quarters as not too conducive for investment to both local and 
foreign investors. Reasons being the inability of financial reports to meet the needs of 
different group users. The prevalence of fraud, excessive earnings management, and other 
financial crimes has reduced the level of confidence reposed in these financial statements. 
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Hence the study aims to investigate how corporate governance structures affect the 
financial reporting quality of quoted pharmaceutical companies in Nigeria. The reaming 
part of the paper is divided into four sections, section two treats a review of related 
literature, section three is the methodology adopted section four deals with data analysis 
and five is on summary of findings, conclusion, and recommendations. 
 
 
Review of related literature 
 
The concept of Corporate Governance 
 
According to Nagw, Hala, and Gamal (2014), corporate governance refers to the structures 
and processes for the management and control of companies. It involves a set of 
relationships between a company’s management, its boards, its shareholders, and other 
stakeholders in a way that provides the structure through which the objective of the 
company is set, and the means of attaining those objectives and monitoring performance 
are determined. Corporate governance is a mechanism of rights and duties by which firms 
are controlled and directed (Pacy, 2012). Obeten, Ocheni, and John (2014) define 
corporate governance as the process that seeks to direct and control the affairs of an 
organization to protect the interest of all stakeholders in a balanced manner with the 
application of the principle of openness, integrity, and accountability. 
 
Gabrielsen, Gramlich, and Plenborg (2012) define corporate governance as all 
encompassing-it concerns how corporate entities are managed and regulated and 
involves accountability, trust, honesty, and stewardship on the hand supervision, control 
monitoring oversight, and ensuring quality financial reporting on the other hand. 
 
Components of corporate governance structure 
 
Board Meeting: This has to do with the number of times the board of directors officially 
meets to discuss issues concerning the company. An important measure of corporate 
board monitoring power and effectiveness is the frequency of board meetings. The 
frequency of board meetings measures the intensity of board activity and the quality or 
effectiveness of its monitoring (Vefeas, 1999; Conger, Finegold, & Lawler, 1998). 
 
Ownership structure: This implies the proportion of the total number of common shares 
owned by the board of directors to the total member of common share outstanding. Barle 
and Means (1932) brought to light the principal agency problem when they argued that 
the separation of ownership from control of modern corporations reduces management 
incentives to maximize corporate efficiency. 
 
Audit Committee: Section 359 of companies and Allied Matters Acts 1990 expressly 
provides for the establishment of an audit committee by quoted companies in Nigeria. 
Usually, the committee is made up (6) six members of equal representation. The Audit 
Committee serves as a bridge between the external Auditor and Board of Directors. They 
view the company’s position in a detached and dispassionate light and often liaised 
between the board and external auditors to ensure that areas of differences are resolved. 
 
Board sizes: Board size is the total number of headcounts of directors seated on the 
company’s board. It comprises the number of individuals serving on the board of a firm 
(Ahmed &Mansur, 2012). The code of governance states that the number of non-executive 
directors should be more than that of executive directors subject to a maximum board size 
of 20 directors (CBN, 2006) and 15 directors (SEC, 2003). Both codes recognize large 
board sizes. 
 
Board Composition: This refers to executive and non-executive directors’ representation 
on the board. Empirical studies on the effect of board membership and structure on firm 
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performance have revealed mixed or opposite results. Some researchers find that firms 
with a board of directors denominated by outsides perform better. 
 
The Risk Management Committee: The Committee assists in the oversight of the risk 
profile, risk management, and risk-reward strategy as determined by the board. Their 
function includes, among others, review and approval of the companies’ risk management, 
reviewing the adequacy and effectiveness of risk across the company and the adequacy of 
prevention, detection, and reprinting mechanism, review laws and regulatory 
requirements that may impact the company’s risk profile. 
 
Board Member Gender: In many countries, the question concerning getting more women 
on boards and in top executive jobs has become a highly debated issue. It is argued that 
women directors on corporate boards after many contributions. Corporations can gain a 
competitive advantage by being receptive to women’s contributions at the top. For 
example, having women on boards impacts the reputation of a company, provides 
strategic input on women’s product/market issues and of board processes and 
deliberations, and contributes to the firms’ female employees. 
 
Concept of financial reporting quality 
 
Verdi (2006) defined financial reporting quality as the exact manner in which it shows 
information regard business activity and its anticipated cash flow, intending to inform the 
shareholder about a company’s operations. Martinez-Ferrero, Garcia-Sanchez, and 
Cuadrado-Ballesters (2013) also defined financial reporting quality as the faithfulness of 
information conveyed in the financial reporting process. Financial reporting is also 
defined as the degree to which financial statements provide us with information that is 
fair and authentic about the financial position and performance of an enterprise (Tang, 
Chen, & Zhijun, 2008). It can be deduced from the above definition that for a financial 
statement to be regarded as possessing a high-quality attribute, it must be able to provide 
genuine authentic information about the economic performance of the firm. 
 
According to Hopen and Kemebradikemor (2019), financial reporting is defined as the 
faithfulness of information conveyed in both the financial and non-financial reporting 
process. The financial statement of firms at the end of a financial year should have some 
element of truth in it. This is termed quality to increase the confidence of users. 
 
Methods of measuring the quality of financial reporting 
 
Financial reporting quality can be accessed directly or indirectly. Directly, it can be 
measured using the Accruals model, the Value relevance model, using specific elements in 
the annual report, and by operation ling the qualitative Characteristics (Beest, Braam, & 
Boelens, 2009). 
 
Accruals Model focuses on the quality of earnings measured, and the major assumption it 
holds is that managers use discretionary accruals to manage earnings (Dechow, Sloan, 
&Sweeny, 1995; Healy & Wahlen, 1999). Earnings management is assumed to negatively 
affect the quality of financial report by reducing it decision usefulness. The main merit of 
this model is that it uses accruals to measure earnings management and is calculated 
based on the information present in the financial statement (Beest, Braam, & Boelens, 
2009). Dechow and Dichev (2002) modified this model called the Jones model, in this 
modified Jones model, accounts receivables were taken into consideration by this model. 
Estimating normal accruals in the first stage is similar to the model. The modified Jones 
reasons that all changes in credit sales in the event period result from earnings 
management.  
 
The modified Dechow and Dichev’s (2002) model is specified as: 
 
ΔWCt= CF0 t-1+ CFO1 + CFOt +1 + ΔSalest+ PPEt+ε 
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Where:  
ΔWC=Working capital in year t, i.e. Accounts receivables+ ΔInventory –Accounts payable 
–Taxes payable +other assets (net) 
CF0 t-1=cash flows from operations in year t-1 
CFO1 = Cash flow from operation in year t; 
CFOt +1 =Cash flows from operation in year t+1 
Salest =Sales in year t less sales in year t-1; 
PPEt  =Gross property, plants, and equipment in year t 
 
This measure of earning quality capotes the extent to which accrual maps into cash flow 
realization in the past, present, and future cash flows. The higher the absolute residual for 
each sample firm, the lower the quality. This model is also supported by the works of 
Nuraddeen and Hasuah (2014). In which the concluded that the Modified Jones model 







This theory is in contrast with agency theory. Stewardship theorist upholds that directors 
frequently have interests that are consistent with those of shareholders. According to 
them, there will not be any major agency cost since managers are naturally trustworthy 
(Donaldson, 2003). Donaldson and Davis (1991) suggest an alternative model where 
organizational role holders are reconceived as being motivated by a need to achieve and 
gain intrinsic satisfaction through successfully performing inherently challenging work, 
to exercise responsibility and authority, and thereby to gain recognition from peers and 
bosses. According to them, where managers have served a corporation for several years, 
there is a merging of individual ego in the corporation. 
 
Stewardship theory postulates that a steward protects and maximizes shareholder wealth 
through firm performance because by doing so, the steward’s utility functions are 
maximized. The steward derives greater utility from satisfying organizational goals than 
through self-serving behavior. The theory recognizes the essentials of structures that 
empower the steward, offering maximizing autonomy built upon trust. The Minimizes the 




Hopen and Kemebradikemor (2019) investigated the impact of board characteristics on 
the financial reporting quality of listed Manufacturing firms. The study made use of a 
deductive research approach using a Multi-method qualitative research approach and 
multi-method qualitative research design, while generalized linear model regression was 
used in testing the hypotheses. Findings revealed that Board expertise was statistically 
significant and positively related to financial reporting quality at5% level of significance, 
while board independence and board diversity were found to be insignificantly related to 
financial reporting quality at5% level of significance. The study concluded that board 
characteristics partially affect financial reporting quality. 
 
Samuel, Mudzamir, and Mohmmad (2017) examined the relationship of audit committee 
size and financial reporting quality of Quoted firms in Nigeria, from 2011-2015 using 189 
companies. Panel data regression was adopted audit committee size was found positive 
and significant with financial reporting quality. Halder and Mishre (2017) examined the 
timeliness of financial reporting and corporate governance. In a study of Indian 
Pharmaceutical industries, the study made use of 50 sample pharmaceutical companies in 
India; it made use of exploratory study. The result shows that the numbers of days taken 
by the sample companies are fluctuating, and there is no consistency between reporting 
companies. 
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Onuorah and Imena (2016) researched corporate governance and financial reporting 
quality in a selection of Nigerian companies. The concerning issue was how corporate 
governance indicators such as structure, audit the quality of external audit quality the 
quality of external audit, and board independence affect financial reporting quality in 
selected Nigeria company. The companies selected were from commodities, brewery, 
banking, oil and gas, and beverages. The period of the study was from 2006-2015. 
Econometric analysis was used for the study. The study concluded that corporate 
governance indicators have a positive impact on financial reporting quality measured by 
the discretionary accruals of a firm.  
 
Ibrahim, Ahmad, John, and Rahma (2016) examined corporate regulations and the quality 
of financial reporting. A proposed study. The issue of concern was to find out how the new 
code regarding the independence of the board in relation to the quality of financial 
information reporting. To find the distinct impact of the code, the paper divided the study 
into two years pre (2010-2011) and two years post (2013-2014) context of the code. The 
study made use of 300 non-financial listed companies’ financial sectors except banks in 
Malaysia. The study used Pearson’s and spearman’s correlation and multiple regressions. 
The study concluded that corporate regulations have effects on quality 
 
Mubarak(2016) examined the impact of Corporate Governance on the quality of financial 
reporting in the Nigerian Chemical and Paint industry. The period of the study was 
between 2009-2103 with a sample of four (4) companies used, and data were analyzed 
using correction regression and the variable used were Board size, Board independence, 
and Audit committee. The study concluded that Board size as well as Board impendence 
has an insignificant effect on the quality of financial reporting in the Nigerian chemical and 
Paint Industry; it went further to say that non-executive directors in the audit committee 
have an insignificant effect. 
 
Ahmed, Cheng, Shamsher, and Tanfia (2016) investigated corporate governance reforms 
and financial reporting quality of Middle East stock markets. The objective was to find out 
the effect of corporate governance reform and financial reporting quality on non-financial 
firms listed at the Saudi stock market before and after the reform was applied to the listed 
firms. The study adopted working capital accruals quality as a measurement of the 
financial reporting quality. An independent sample t-test was performed to investigate the 
trend of the FRQ in the selected countries. The result shows that the applied corporate 
governance reform was efficient, and the FRQ improve for the era after corporate 
governance reform in the Middle East stock market. The study period was 1996-2011.  
 
Popove, Georgakopoulos, Sotiropoulos, and Vasileirus (2013) investigated the 
relationship between mandatory disclosure and financial reporting quality using a sample 
of UK companies included in the FTSE350 index. The findings showed that the average 
mandatory disclosure index for five years period is 91.51 %( with a minimum of 69.31% 





Considering the divergent results of empirical works reviewed above, this study 
hypothesizes that: corporate governance mechanisms (Board independence, Board 
composition, Number of Board meeting, and Ownership structure, number of Risk 
Management Committee meetings, Number of female membership, and number of Audit 
committee members) do not have a significant effect on financial reporting quality of 
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The research design adopted for the study was ex-post facto as the study used documented 
dates that were extracted from the annual report and accounts of the sampled firms. Given 
the use of documented data for the study, the uses of ex-post facto research design are 
thought justified and, as such, are not subject to manipulation. Purposive sampling was 
used to select ten quoted Pharmaceutical firms in Nigeria that have a complete data point 
for the relevant number of years. The study period of the research is from 2006-2019. 
 
Source of data 
 
To assess Corporate Governance structure on financial reporting quality, the data selected 
for the research were secondary in nature and collected from the published audited 




The study is based on the corporate governance structure and financial reporting quality 
of listed pharmaceutical companies in Nigeria. Financial reporting quality is the 
dependent variable. In this study, Modified Accrual Model is used to compute the financial 
reporting quality proposed by Dechow and Dichev (2002). 
 




ΔWCt= CF0 t-1+ CFO1 + CFOt +1 + ΔSalest+ PPEt+ε 
Where:  
ΔWC=Working capital in year t, i.e. Accounts receivables+ ΔInventory –Accounts payable 
–Taxes payable +other assets (net) 
CF0 t-1=cash flows from operations in year t-1 
CFO1 = Cash flow from operation in year t; 
CFOt +1 =Cash flows from operation in year t+1 
Salest =Sales in year t less sales in year t-1; 
PPEt =Gross property, plants, and equipment in year t 
 
The independent variables in the study are Board composition, Board Size, the number of 
Board meetings, Ownership structure, Gender composition, Risk management committee, 




The statistical tool of the model for testing the hypotheses is expressed as follows: 
 
AM=     β0+β1BCOMP+𝛃2 BC+𝛃3 BM, +𝛃4 OS, + 𝛃4+ OS, + 𝛃5 RMC+β6 GC+𝛃7AC +µ ……..1 
 
Where:  
Am= Accrual Model   -Proxy for Financial reporting quality     
β0= estimated of the true intercept β0, β1 , β2 , β3, β4 , β5, β6 and, β7 are parameters to be 
estimated  
µ=stochastic term 
BI   = Board Independent 
BC = Board Composition 
BM= Board Meeting 
OS = Ownership Structure 
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RMC = Risk Management Committee 
GC = Gender Composition 





In analyzing the effect of corporate governance on the financial reporting quality of quoted 
manufacturing companies in Nigeria, multiple regression and Pearson correlation 
coefficients were used to analyze the data with the aid of E views statistical software.  
 
Descriptive analysis for the pharmaceutical sector 
 
The seven corporate governance indicators selected for this study and also accrual, which 
served as a proxy for financial reporting quality, were extracted from the financial reports 
of the different pharmaceutical companies in Nigeria to form a panel study data. All the 
variables were descriptively analyzed to obtain some idea as it pertains to their behavior 
in terms of spread and variability. The essence is to serve as a guide to further analyses 
made in the course of this research work. The results of the descriptive statistics for all 
the variables are shown in Table 1 below. 
 
Table 1. Result of Descriptive Analysis 
 BI BC BM OS RMC GC AC LOGACCRUAL 
 Mean  1.852917  0.629750  4.066667  0.223302  2.766667  1.824292  5.100000  0.803982 
 Median  1.600000  0.640000  4.000000  0.217087  3.000000  2.000000  6.000000  0.475671 
 Maximum  4.500000  0.800000  6.000000  0.337393  5.000000  5.000000  6.000000  2.168792 
 Minimum  0.800000  0.300000  3.000000  0.178151  0.000000  0.080000  4.000000  0.143015 
 Std. Dev.  1.014502  0.822736  0.590304  0.889741  1.261807  1.633980  0.990713  0.663804 
 Skewness  1.189090  1.141644  1.217239 -0.608930 -0.133778  0.338142 -0.200986  1.128208 
 Kurtosis  3.386955  3.052241  6.488891  2.172374  2.473789  1.867642  1.057691  2.798221 
 Jarque-Bera  29.02739  16.08066  90.49519  10.84075  1.742421  8.697977  19.67072  25.66063 
 Probability  0.000000  0.000002  0.000000  0.004425  0.418445  0.012920  0.000054  0.000003 
 Sum  222.3500  135.5700  488.0000  102.7962  332.0000  218.9150  612.0000  96.47790 
 Sum Sq. Dev.  122.4765  80.55049  41.46667  94.20503  189.4667  317.7170  116.8000  52.43563 
 Observations  120  120  120  120  120  120  120  120 
Source: Researcher’s Eviews Output 2018 
 
The result of the descriptive analyses as contained in Table1 above indicates that board 
independence is widely varied but not equitably spread its mean. The observations flow 
from the minimum of 0.80 to a maximum of 4.50 but have an overall tendency towards 
the minimal level, as is evidenced by its median score of 1.60. this result of the median is 
even more supported by the outcome of the mean, which is 1.85, thereby suggesting most 
of our selected pharmaceutical companies for the various years maintained board 
independence of two non-executive directors to one executive director as against the 
implication of the maximum outcome which appears to be on a high side of four non-
executive directors to one executive director.  
 
Board composition has a considerable level of variability in comparison to board 
independence. This suggests that the variations in the ratio of non-executive directors to 
the total number of directors within the pharmaceutical sector in this study are fairly 
spread, as can be deduced by its median score of 0.64 and mean score of 0.63 
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approximately. This finding implies that selected pharmaceutical firms in this study 
maintained a high number of non-executive directors in relation to the total number of 
directors in each of the firms within the years covered in the study. As suggested in the 
findings for board independence, this high number of non-executive directors is around 
two for everyone executive director (66%) on average. This is an indication that board 
compositions across the ten selected pharmaceutical companies in this study were 
dominated by non-executive directors on average, but at some few points or in some 
companies, the ratio of the compositions was rather low as depicted by the minimum 
board composition, which can be interpreted as3 non-executive directors out of a total of 
10 directors. 
 
Board meetings, according to the result obtained in the above Table1, increased from the 
minimum value of 3 times per year to a maximum of 6 times in a year across the ten 
selected pharmaceutical firms. This level of variability is narrower than the range of 
disparity that was obtained for the board composition, thereby suggesting comparable 
behavior for selected firms within the pharmaceutical sector in terms of board meeting 
frequencies. Concerning the spread of the variables around the mean, the results show 
that board meetings have held an average of four times in year across the ten selected 
firms in this section of the study. The median outcome of 4.00 approximately also shows 
that the disparity that could exist in the frequencies of board meetings for pharmaceutical 
companies selected in this study is evenly spread. So, it can be concluded that board 
meetings in the pharmaceutical sector were held an average of 4 times within the years 
covered in this study. 
 
Ownership structure for the pharmaceutical sector, on the other hand, does not possess 
much variability as its peak is 0.34 approximately with the lowest value of 0.18; thus, the 
median outcome of 0.22 suggests that the observations for ownership structure are 
dominantly close to the minimum value than they are to the maximum outcome. It also 
implies that directors’ shareholdings in the selected pharmaceutical firms in this study are 
more inclined to be around 22% approximately. The implication for the median is also 
supported by the mean value of 22%, which indicates that an average firm in the 
pharmaceutical sector has an ownership structure of 22% shareholdings by its directors. 
 
The number of times members of the risk management committee meet on average in a 
given year is three times approximately, whereas the mid-value of all the observations is 
also three times annually. However, this general perspective may becloud the cases of 
extremities in the data range of the whole companies in this sector. Thus, the minimum 
value of 0.00 reveals that some selected pharmaceutical companies do not have risk 
committee management meetings throughout some of the years covered in this study, 
whereas the maximum outcome of 5 times also suggests that some companies had the 
same meetings for up to 5 times in a year. It is also no Table that risk management 
committee meetings for the pharmaceutical sector have an average of 3 times per year 
which suggests that the selected firms in the study each conducts risk management 
meetings three times on average. The median value also supports this outcome since it 
implies that between the maximum and minimum, which are five times and nil 
respectively, more firms in the selection and the years covered are inclined to having the 
meetings from 3 to 5 times in a year. Hence, we conclude that risk management committee 
meetings are held three times on average by firms in the pharmaceutical sector and that 
the observations are considerably tilted to the maximum value. 
 
Gender composition for the pharmaceutical sector shows a maximum value of 5 and 
indicates that at least one of the selected pharmaceutical companies at some point within 
the 12 years covered in this work has a composition of 5 female board members to one 
male. This outcome is rather rare as none of the previous sectors in this work has had up 
to one female to one male directors’ composition. However, the outcomes of both the mean 
and median scores indicate that more observations for gender compositions of the boards 
tend towards2 females to 1 male board member. This result suggests that female 
members dominate the board compositions of pharmaceutical companies in Nigeria. 
234 | Kalu Ogbonnaya AMAH, Michael Chidiebere EKWE 
Effect of Corporate Governance Structure and Financial Reporting Quality of Quoted Pharmaceutical 
Companies in Nigeria 
 
Audit Committee membership in the results of the descriptive statistics shown in Table1 
above is five members on the average for pharmaceutical companies in this work. The 
median value of 6.00 as against the maximum of 6 suggests that at least half of the total 
observations on audit committee members of pharmaceutical companies are six 
members, whereas the other half may be a combination of 6, 5, and 4, which is the 
minimum value. This highlights the possibility that most firms in the panel of the ten 
selected pharmaceutical companies may have maintained audit membership strength of 
up to 6, whereas lower audit committee strength of 5 and 4 members was only maintained 
minimally.  
 
The financial reporting quality of selected pharmaceutical companies in this study 
captured by accrual is not considerably varied considering its minimum logged value of 
0.14 as against the maximum value of 2.17 approximately. The observations are not fairly 
dispersed as its median value of 0.48 approximately suggests that the variable is rather 
tilted to the minimum value. The results here, therefore, suggest that our selected firms 
may have few companies with higher accrual values than the rest. It can also mean that 
some of the selected companies got very high and low accrual outcomes in different years 
within the years covered in this work. 
 
Discussion of pharmaceutical sector regression results 
 
This section deals with the estimation of the regression analysis for all the corporate 
governance indicators on the financial reporting quality of selected firms within the 
pharmaceutical sector, and this was done using a fixed/random-effects model, which 
makes a selection from two regression estimates based on the outcome of the Hausman 
test. 
 
The pair of hypotheses proposed by the Hausman test analyses consists of:  
H0: Random effect regression model is more appropriate.  
H1: Fixed effect regression model is more appropriate. 
 
Table 2. Hausman Test for Fixed and Random Effects Models 
Correlated Random Effects - Hausman Test  
Equation: Untitled   
Test cross-section random effects  
Test Summary Chi-Sq. Statistic Chi-Sq. d.f. Prob.  
     
Cross-section random 5.257365 7 0.6286 
     
 
Cross-section random effects test comparisons: 
Variable Fixed   Random  Var (Diff.)  Prob.  
     
BI 0.052341 0.052276 0.000000 0.8185 
BC 0.072058 0.070050 0.000003 0.2527 
BM(-1) -0.004791 -0.004604 0.000000 0.5117 
OS(-2) 0.045342 0.046125 0.000000 0.2464 
RMC 0.007374 0.007224 0.000000 0.4475 
GC 0.016408 0.016346 0.000000 0.8702 
AC 0.005474 0.005064 0.000001 0.6037 
     
Source: Researcher’s Eviews Computation 2018 
 
According to the result obtained for the Hausman test of the selected companies in the 
pharmaceutical sector in Table2 above, the result for the Chi-square statistics of the 
Hausman test is not significant at 5%, so we accept the null hypothesis. The null 
hypothesis of the above test proposes the acceptance of the random effect model, which 
assumes a mean value for the intercepts of the various selected pharmaceutical 
companies, whereas the alternative hypothesis suggests that the fixed effect regression 
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model is appropriate, including the assumption that though intercepts may differ among 
the various firms, it remains time-invariant. 
 
However, the result of the Hausman test having a probability value that is more than 5% 
accepted benchmark will lead to acceptance of the null hypothesis and conclusion that the 
random effect regression model is the appropriate model for the regression analysis of the 
pharmaceutical sector. 
 
Table 3. Panel multiple regression of corporate governance indicators on financial 
reporting quality of pharmaceutical companies in Nigeria 
Source: Researcher’s Eviews Computations 2018 
 
Hence based on the Hausman test results, we use the random effect regression result in 
Table3 to explain the association of corporate governance structures and financial 
reporting quality. 
 
According to the regression result, the beta coefficient of board independence yields a 
positive value which suggesting that board independence of the firms attracts a direct 
response from the financial reporting quality of selected firms. The implication is that 
positive variations in the ratio of non-executive directors to the number of executive 
directors in the pharmaceutical companies’ boards will be associated with a 
corresponding positive reaction from the financial reporting quality of the pharmaceutical 
companies at a statistically significant level of 1%. Hence the study concludes that board 
independence has a significant and positive influence on the financial reporting quality of 
pharmaceutical companies; thus, decisions concerning corporate governance, especially 
as it concerns board independence, should always consider possible effects it tends to 
offset on the financial reporting quality of the firm. These results tally’s with the findings 
of Onurorah and Imen (2016). But it remarkably differs from previous studies by Gois 
Dependent Variable: LOGACCRUAL  
Method: Panel EGLS (Cross-section random effects) 
Date: 09/06/18   Time: 16:02   
Sample (adjusted): 2008 2017   
Periods included: 10   
Cross-sections included: 10   
Total panel (balanced) observations: 100  
Swamy and Arora estimator of component variances 
Variable Coefficient Std. Error t-Statistic Prob.   
C 0.761235 0.273608 2.782207 0.0066 
BI 0.052276 0.008961 5.833909 0.0000 
BC 0.070050 0.025373 2.760819 0.0070 
BM(-1) -0.004604 0.011589 -0.397268 0.6921 
OS(-2) 0.046125 0.013634 3.383001 0.0011 
RMC 0.007224 0.005792 1.247152 0.2155 
GC 0.016346 0.007803 2.094677 0.0389 
AC 0.005064 0.014891 0.340083 0.7346 
 Effects Specification   
   SD.   Rho   
Cross-section random 0.783276 0.9960 
Idiosyncratic random 0.049788 0.0040 
 Weighted Statistics   
R-squared 0.552694     Mean dependent var 0.016267 
Adjusted R-squared 0.511051     S.D. dependent var 0.064259 
S.E. of regression 0.049314     Sum squared resid 0.223732 
F-statistic 10.87087     Durbin-Watson stat 1.711553 
Prob(F-statistic) 0.000000    
 Unweighted Statistics   
 
R-squared 0.423935     Mean dependent var 0.809422 
Sum squared resid 44.67452     Durbin-Watson stat 1.607570 
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(2014), Uwuigbe, and Oyemiyi (2014), who found Board independence to be insignificant 
to the financial reporting quality of pharmaceutical firms. 
 
Board composition also has a positive and significant effect on the financial reporting 
quality of pharmaceutical companies. The implication is that the financial reporting 
quality of the selected pharmaceutical firms responds to changes in the board composition 
of pharmaceutical companies in the same direction as board composition. The finding 
here is in agrees with the idea proper inclusion of non-executive directors who are not 
servants of the company into its board will promote decisions made as the non-executive 
directors tend to judge issues objectively, having no self-review threat when there is a 
need to appraise team performance. Hence, we conclude in line with the outcome of the 
beta coefficient (0.05) and probability of the t-statistics (1%) on Table 4.28 above that the 
board composition of selected pharmaceutical companies in this study has a significant 
and positive influence on financial reporting. Akeju and Babatude (2017) and Garba 
(2014) support these findings that Board Compositions help to befit up financial reporting 
quality. 
 
However, board meetings have a negative association with the financial reporting quality 
of selected pharmaceutical companies at the lag length of one year. This indicates that 
frequencies of board meetings for the selected companies in the pharmaceutical sector of 
Nigeria are associated with a negative reaction in the financial reporting quality after the 
space of one year. It also implies that the board meetings of the selected companies are 
not yet optimal to attract a direct reaction from their financial reporting quality even 
though the t-statistics of the beta coefficient is not within the accepted statistical bound of 
5%. The study, therefore, concludes that board meetings of selected pharmaceutical 
companies in this study have a negative and non-significant effect on their financial 
reporting quality. This finding is in with Waidi & Karreem (2017) that Board meetings do 
not have a significant effect on financial reporting quality in that we do not know the 
quality of meeting they have and the number that attended the meeting, which concluded 
that Board meetings are a weak predictor of financial reporting quality. 
 
Owners’ structure was lagged at the length of two years to obtain a positive influence on 
the financial reporting quality of the sampled pharmaceutical firms, according to the 
findings contained in Table 4.28 above.  The implication of this finding could be that the 
more directors are grafted to become financial stakeholders in the companies they are 
managing, the better their performance in maintaining the quality of the financial reports. 
The positive association between owners’ structure and financial reporting quality of 
these selected companies in the pharmaceutical sector is also found to be significant at 
1%, suggesting that the relationship that flows from owners ‘structure to financial 
reporting quality can be relied upon in making statistical predictions and inferences. This 
result also agrees with the result of the Granger Causality Test, which states that owners’ 
structure has a causal and significant influence on the financial reporting of firms in the 
pharmaceutical sector. So in the light of these findings, we conclude that owners’ structure 
as a vector of corporate governance has a significant and positive effect on the financial 
reporting of firms after two years lagged. This result is supported by the works of Adebiyi 
and Olorokee (2016), Faith (2013), Jamil Al-Suly (2013) found that ownership structure 
is a determinant of financial reporting quality. 
 
Risk management committee meetings yield a direct influence on the financial reporting 
quality of selected companies in Nigeria, as shown in Table 4.28 above. This view is 
obtained from the fact that the beta coefficient for the risk management committee (RMC) 
is 0.007, approximately suggesting that the frequency of annual risk management 
committee meetings of the ten selected companies has a positive relationship with the 
financial reporting quality of the pharmaceutical firms. This finding suggests that the 
financial reporting quality of companies in the pharmaceutical sector responds positively 
to the frequency of risk management committee meetings and also implies that the 
activities of the committee contribute to the effectiveness of financial reporting of the 
companies even though it is non-significant. So, in consideration of the probability of the 
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t-statistics of risk management committee meetings which is above 5%, we conclude that 
risk management committee meetings as an indicator of corporate governance of firms 
have no significant influence on financial reporting quality. 
 
Gender compositions of selected pharmaceutical companies have a positive and 
significant effect on financial reporting quality. This outcome implies that the numerical 
strength of female to male board members yields a significant and positive effect on the 
financial reporting quality of the pharmaceutical companies in Nigeria. It follows that the 
dilution of male dominance in the composition of the board of directors of the companies 
shows a positive and significant effect on the financial reporting quality of the 
pharmaceutical companies selected in this study.  
 
However, the number of audit committee members of pharmaceutical firms over the 
selected years in this study, on the other hand, attracts a positive response from the 
variations occurring in their financial reporting quality. But the association is not 
statistically significant at 5%; we conclude that the audit committee has a positive but 
non-significant influence on the financial reporting quality of the firms within the 
pharmaceutical sector in Nigeria. This is in line with the findings of Oluchukwu and 
Somtochukwu (2017). Moses, Ofurum, and Egbe (2016) found it to be a poor predictor for 
financial reporting quality in the pharmaceutical companies selected in this study 
 
The residual statistics of the multiple regression models in Table3 also support the beta 
coefficients of the individual variables, thereby strengthening the implications of the 
results. The r-squared of 0.55 suggests that our regression model, which regressed 
corporate governance indicators on financial reporting quality of pharmaceutical 
companies, is well-fitted.  This is because the r-squared outcome of 55% shows the ability 
of the selected explanatory variables to predict more than half of the changes that occur 
in the financial reporting quality of the selected pharmaceutical firms in Nigeria.  
 
The probability value of the f-statistics is significant at 1% supporting the credibility of 
the regression equation and powers of the independent variables in predicting changes 
that occur in the financial reporting quality of the selected pharmaceutical companies. The 
Durbin-Watson statistics which has a value of 1.72being close to 2 supports the outcome 
of the regression model and also suggests the near absence of autocorrelation among the 
series that estimated the above regression model. 
 
Conclusion and recommendations 
 
This study was targeted at unveiling the importance of corporate governance structures 
in enhancing financial reporting credibility and reducing opportunistic behavior in the 
Nigeria Pharmaceutical industry. Hausman test of multiple regression was employed to 
investigate the hypothesized relationship. In line with the previous works, discretionary 
accrual was used as a proxy for financial reporting quality. Results revealed that Board 
Independence, Board Computation, Ownership structure, Risk Management Committee, 
Gender composition, and Audit committee have a positive association, while Board 
Meeting has a negative impact on financial reporting quality. Based on the findings of this 
study, the following policy recommendations are proposed: This study recommends that 
the SEC Code of Corporate Governance (2003) on the attendance of Board meetings. This 
study also recommends to regulators that in addition to the independence of the Audit 
Committee, the Chairman of the Audit should be a person with strong financial analysis 
background or a Professional Accountant. Regular and spontaneous supervision 
function/checks by the different regulatory agencies are also recommended, while stiff 
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